An exploratory study of dialectical behaviour therapy for emotional dysregulation and challenging behaviours after acquired brain injury.

Acquired brain injury challenging behaviours dialectical behaviour therapy emotion regulation

Journal

NeuroRehabilitation
ISSN: 1878-6448
Titre abrégé: NeuroRehabilitation
Pays: Netherlands
ID NLM: 9113791

Informations de publication

Date de publication:
12 Jul 2024
Historique:
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 20 7 2024
Statut: aheadofprint

Résumé

Challenging behaviours and emotional dysregulation are common sequelae of acquired brain injury (ABI), but treatment remain underdeveloped. Dialectical behaviour therapy is an evidence-based therapy for emotional dysregulation. To explore the feasibility and preliminary efficacy of dialectical behaviour therapy for ABI. An exploratory longitudinal study that compared thirty adults with brain injury presenting persistent emotion dysregulation or challenging behaviours. Control group received a personalized multidisciplinary program only (n = 13). The dialectical behaviour therapy group received five months of emotion regulation skills learning as an add-on (n = 17). Preliminary efficacy was measured on Difficulties in Emotion Regulation Scale-16 and Quality of Life after Brain Injury total score and emotion subscore. Fourteen participants completed the dialectical behaviour therapy. This study provided preliminary evidence for the feasibility and acceptability of dialectical behaviour therapy. Repeated measures revealed improvement on the Difficulties in Emotion Regulation Scale-16 (-7.6 [-17.3; 1.7]; Pr = 0.95) and on the Quality Of Life emotion subscore (13.5 [-3.8; 30.9]; Pr = 0.94). This study raises important questions regarding the type of patients who can benefit from this intervention, necessary adaptations of dialectical behaviour therapy and the way it can help post-traumatic growth and identity reconstruction after ABI.

Sections du résumé

BACKGROUND UNASSIGNED
Challenging behaviours and emotional dysregulation are common sequelae of acquired brain injury (ABI), but treatment remain underdeveloped. Dialectical behaviour therapy is an evidence-based therapy for emotional dysregulation.
OBJECTIVE UNASSIGNED
To explore the feasibility and preliminary efficacy of dialectical behaviour therapy for ABI.
METHODS UNASSIGNED
An exploratory longitudinal study that compared thirty adults with brain injury presenting persistent emotion dysregulation or challenging behaviours. Control group received a personalized multidisciplinary program only (n = 13). The dialectical behaviour therapy group received five months of emotion regulation skills learning as an add-on (n = 17). Preliminary efficacy was measured on Difficulties in Emotion Regulation Scale-16 and Quality of Life after Brain Injury total score and emotion subscore.
RESULTS UNASSIGNED
Fourteen participants completed the dialectical behaviour therapy. This study provided preliminary evidence for the feasibility and acceptability of dialectical behaviour therapy. Repeated measures revealed improvement on the Difficulties in Emotion Regulation Scale-16 (-7.6 [-17.3; 1.7]; Pr = 0.95) and on the Quality Of Life emotion subscore (13.5 [-3.8; 30.9]; Pr = 0.94).
CONCLUSION UNASSIGNED
This study raises important questions regarding the type of patients who can benefit from this intervention, necessary adaptations of dialectical behaviour therapy and the way it can help post-traumatic growth and identity reconstruction after ABI.

Identifiants

pubmed: 39031392
pii: NRE230383
doi: 10.3233/NRE-230383
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Marie Kuppelin (M)

INSERM UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, University of Strasbourg, Strasbourg, France.
EMOI-TC Service, Clémenceau University Institute of Rehabilitation, UGECAM Alsace, Strasbourg, France.

Antoine Goetsch (A)

EMOI-TC Service, Clémenceau University Institute of Rehabilitation, UGECAM Alsace, Strasbourg, France.
Service of Physical Medicine and Rehabilitation, Clémenceau University Institute of Rehabilitation, UF 4372, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Régine Choisel (R)

EMOI-TC Service, Clémenceau University Institute of Rehabilitation, UGECAM Alsace, Strasbourg, France.

Marie-Eve Isner-Horobeti (ME)

Service of Physical Medicine and Rehabilitation, Clémenceau University Institute of Rehabilitation, UF 4372, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
EA3072 Mitochondria, Oxidative Stress and Muscle Protection, Strasbourg University, Strasbourg, France.

Thibaut Goetsch (T)

Department of Public Health, Strasbourg University Hospital, GMRC, Strasbourg, France.

Agata Krasny-Pacini (A)

INSERM UMR-S 1329, Strasbourg Translational Neuroscience and Psychiatry, University of Strasbourg, Strasbourg, France.
EMOI-TC Service, Clémenceau University Institute of Rehabilitation, UGECAM Alsace, Strasbourg, France.
Service of Physical Medicine and Rehabilitation, Clémenceau University Institute of Rehabilitation, UF 4372, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.

Classifications MeSH